Barclays PLC increased its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) by 2.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 780,159 shares of the real estate investment trust’s stock after purchasing an additional 19,742 shares during the quarter. Barclays PLC owned 0.34% of Sabra Health Care REIT worth $10,235,000 at the end of the most recent quarter.
→ The Next Big Crisis Is Here (From Porter & Company)
Other large investors have also made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new position in shares of Sabra Health Care REIT in the 2nd quarter valued at about $31,000. JFS Wealth Advisors LLC purchased a new position in shares of Sabra Health Care REIT in the 2nd quarter valued at about $32,000. Lazard Asset Management LLC purchased a new position in shares of Sabra Health Care REIT in the 2nd quarter valued at about $38,000. Lindbrook Capital LLC increased its holdings in shares of Sabra Health Care REIT by 60.8% in the 2nd quarter. Lindbrook Capital LLC now owns 2,929 shares of the real estate investment trust’s stock valued at $41,000 after purchasing an additional 1,107 shares in the last quarter. Finally, Worth Asset Management LLC purchased a new position in shares of Sabra Health Care REIT in the 1st quarter valued at about $44,000. Hedge funds and other institutional investors own 87.20% of the company’s stock.
Sabra Health Care REIT Stock Up 0.9 %
Sabra Health Care REIT stock opened at $13.27 on Friday. Sabra Health Care REIT, Inc. has a 12-month low of $11.44 and a 12-month high of $16.60. The firm’s 50-day moving average is $12.76 and its two-hundred day moving average is $13.65. The company has a quick ratio of 2.90, a current ratio of 2.90 and a debt-to-equity ratio of 0.76.
Sabra Health Care REIT Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, November 30th. Shareholders of record on Thursday, November 17th were paid a dividend of $0.30 per share. The ex-dividend date was Wednesday, November 16th. This represents a $1.20 annualized dividend and a dividend yield of 9.04%. Sabra Health Care REIT’s dividend payout ratio is currently -1,500.00%.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on SBRA shares. StockNews.com started coverage on shares of Sabra Health Care REIT in a report on Wednesday, October 12th. They set a “hold” rating for the company. Bank of America downgraded shares of Sabra Health Care REIT from a “neutral” rating to an “underperform” rating and dropped their target price for the company from $15.00 to $13.00 in a report on Monday, November 14th. Robert W. Baird downgraded shares of Sabra Health Care REIT from an “outperform” rating to a “neutral” rating and set a $13.00 target price for the company. in a report on Monday, October 10th. Finally, JMP Securities downgraded shares of Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a report on Tuesday, December 13th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $15.00.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sabra Health Care REIT, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Sabra Health Care REIT wasn’t on the list.
While Sabra Health Care REIT currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
Source: news.google.com
